ResMed

$183.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$7.16 (-3.76%) Today

$0.00 (0.00%) As of 12:45 AM UTC after-hours

Why Robinhood?

You can buy or sell ResMed and other stocks, options, and ETFs commission-free!

About RMD

ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA. The listed name for RMD is ResMed Inc.

CEO

Michael J. Farrell

Employees

7,770

Headquarters

San Diego, California

Founded

1989

Market Cap

26.58B

Price-Earnings Ratio

40.37

Dividend Yield

0.81

Average Volume

698.79K

High Today

$190.08

Low Today

$181.28

Open Price

$189.30

Volume

984.74K

52 Week High

$224.43

52 Week Low

$108.85

RMD News

MarketWatch3h

ResMed Inc. stock underperforms Thursday when compared to competitors

Shares of ResMed Inc. RMD shed 3.76% to $183.05 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index

Analyst Ratings

33%

of 18 ratings

Buy

33%

Hold

50%

Sell

17%

RMD Earnings

$0.00

$0.47

$0.94

$1.41

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Apr 29, After Hours